Showing results (181-190 of 12,921) with videos related to

Sort By:
Pageof 1,293
European Heart Journal|April 20, 2010
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trialDavid A Morrow, Elliott M Antman, Keith A A Fox, et al.
European Heart Journal|August 7, 2008
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trialSabina A Murphy, Elliott M Antman, Stephen D Wiviott, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapyJessica L Mega, David A Morrow, Christopher P Cannon, et al.
American Heart Journal|April 1, 1989
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct SizeS Pohjola-Sintonen, J E Muller, P H Stone, et al.
American Heart Journal|June 21, 2002
Identification of patients at high risk for death and cardiac ischemic events after hospital dischargeMarc S Sabatine, Carolyn H McCabe, David A Morrow, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 TrialSungha Park, Brian A Bergmark, Minggao Shi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.
JAMA|August 11, 2000
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision makingE M Antman, M Cohen, P J Bernink, et al.
European Heart Journal|December 28, 2018
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze-Fan Chao, Shih-Ann Chen, Christian T Ruff, et al.
JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Pageof 1,293